Global Hospital-Acquired Infection Control Market

Hospital-Acquired Infection Control Market Size, Share, Growth Analysis, By Product & Service Sterilization(Sterilization, Sterilization Product, Heat Sterilization Equipment, Low Temperature Sterilization Equipment), By Infection(Hospital-acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections), By End-User(Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2598 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 104 | Figures: 72

Hospital-Acquired Infection Control Market Insights

Hospital-Acquired Infection Control Market size was valued at USD 34,007.11 Million in 2023 and is poised to grow from USD 36489.63 Million in 2024 to USD 47278.92 Million by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The market for Hospital Acquired Infections (HAIs) is being propelled by several key factors. Heightened awareness surrounding the significance of curbing cross infections, coupled with the prevalence of infectious diseases within healthcare facilities, serves as a primary driver. Moreover, supportive government initiatives aimed at promoting infection control practices contribute significantly to market growth.

The establishment of rigorous infection prevention standards and protocols, implemented at various levels from hospitals to regional and national scales, plays a pivotal role in fostering a culture of safety and hygiene. Additionally, the increasing adoption of monitoring solutions further amplifies this trajectory, facilitating proactive measures to prevent and manage HAIs effectively.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Hospital-Acquired Infection Control Market size was valued at USD 32,998.89 million in 2022 and is poised to grow from USD 34,007.11 million in 2023 to USD 44,062.37 million by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

The competitive environment of the hospital-acquired infection control market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. '3M Company', 'Becton, Dickinson and Company', 'STERIS plc', 'Getinge AB', 'Tuttnauer Ltd.', 'Olympus Corporation', 'Xenex Disinfection Services Inc.', 'ASP (Advanced Sterilization Products)', 'Ecolab', 'Belimed AG', 'KCWW (Kimberly-Clark Worldwide, Inc.)', 'MATACHANA GROUP', 'MMM Group', 'Belimed AG', 'Reckitt Benckiser', 'Metrex Research LLC'

In recent years, there has been a substantial upsurge in the count of surgical procedures conducted annually. As per the World Health Organization's data from 2022, an estimated 330 million major surgical procedures are carried out worldwide each year. Several factors contribute to this remarkable increase. The prevalence of conditions like obesity and various lifestyle-related diseases has been steadily rising, necessitating surgical interventions for treatment and management.

Ethylene oxide stands out as one of the most efficient gaseous sterilizing agents, particularly suitable for instruments that are sensitive to high temperatures, such as plastic instruments or those incorporating electrical components. Despite its efficacy, concerns have been raised regarding the potential health risks associated with ethylene oxide exposure.

North America emerged as the dominant force within the market, securing a substantial revenue share exceeding 34.0% in 2022. This commanding presence can be attributed to several key factors shaping the region's healthcare landscape. The region boasts the presence of key industry players actively engaged in combating Hospital Acquired Infections (HAIs) through comprehensive initiatives spanning both public and private sectors.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Hospital-Acquired Infection Control Market

Report ID: SQMIG35A2598

$5,300
BUY NOW GET FREE SAMPLE